132 related articles for article (PubMed ID: 35309123)
1.
Khan MA; Massey S; Ahmad I; Sadaf ; Akhter N; Habib M; Mustafa S; Deo SVS; Husain SA
Front Genet; 2022; 13():842943. PubMed ID: 35309123
[No Abstract] [Full Text] [Related]
2. FOXO3 gene hypermethylation and its marked downregulation in breast cancer cases: A study on female patients.
Khan MA; Sadaf ; Ahmad I; Aloliqi AA; Eisa AA; Najm MZ; Habib M; Mustafa S; Massey S; Malik Z; Sunita K; Pawar JS; Akhter N; Shukla NK; Deo SVS; Husain SA
Front Oncol; 2022; 12():1078051. PubMed ID: 36727057
[TBL] [Abstract][Full Text] [Related]
3. Mutation, methylation and expression analysis of LIFR gene in Indian breast cancer patients.
Real SAS; Parveen F; Rehman AU; Shaik R; Deo SVS; Husain SA
Mutat Res; 2019 Nov; 816-818():111677. PubMed ID: 31557600
[TBL] [Abstract][Full Text] [Related]
4. Aberrant Promoter Methylation of YAP Gene and its Subsequent Downregulation in Indian Breast Cancer Patients.
Real SAS; Parveen F; Rehman AU; Khan MA; Deo SVS; Shukla NK; Husain SA
BMC Cancer; 2018 Jul; 18(1):711. PubMed ID: 29970036
[TBL] [Abstract][Full Text] [Related]
5. Forkhead box O-class 1 and forkhead box G1 as prognostic markers for bladder cancer.
Kim TH; Jo SW; Lee YS; Kim YJ; Lee SC; Kim WJ; Yun SJ
J Korean Med Sci; 2009 Jun; 24(3):468-73. PubMed ID: 19543511
[TBL] [Abstract][Full Text] [Related]
6. Promoter Hypermethylation of the ATM Gene as a Novel Biomarker for Breast Cancer.
Begam N; Jamil K; Raju SG
Asian Pac J Cancer Prev; 2017 Nov; 18(11):3003-3009. PubMed ID: 29172272
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic Alteration and its Association With Downregulated FOXP3 Gene in Indian Breast Cancer Patients.
Sadaf ; Akhter N; Alharbi RA; Sindi AAA; Najm MZ; Alhumaydhi FA; Khan MA; Deo SVS; Husain SA
Front Genet; 2021; 12():781400. PubMed ID: 34938323
[No Abstract] [Full Text] [Related]
8. Protein expression and methylation of MGMT, a DNA repair gene and their correlation with clinicopathological parameters in invasive ductal carcinoma of the breast.
Asiaf A; Ahmad ST; Malik AA; Aziz SA; Rasool Z; Masood A; Zargar MA
Tumour Biol; 2015 Aug; 36(8):6485-96. PubMed ID: 25820821
[TBL] [Abstract][Full Text] [Related]
9. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-9 promotes the proliferation, migration, and invasion of breast cancer cells via down-regulating FOXO1.
Liu DZ; Chang B; Li XD; Zhang QH; Zou YH
Clin Transl Oncol; 2017 Sep; 19(9):1133-1140. PubMed ID: 28397066
[TBL] [Abstract][Full Text] [Related]
12. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
Jiang Y; Tong D; Lou G; Zhang Y; Geng J
Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
[TBL] [Abstract][Full Text] [Related]
13. Acylglycerol kinase promotes cell proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Wang X; Lin C; Zhao X; Liu A; Zhu J; Li X; Song L
Mol Cancer; 2014 May; 13():106. PubMed ID: 24886245
[TBL] [Abstract][Full Text] [Related]
14. Post-transcriptional repression of FOXO1 by QKI results in low levels of FOXO1 expression in breast cancer cells.
Yu F; Jin L; Yang G; Ji L; Wang F; Lu Z
Oncol Rep; 2014 Mar; 31(3):1459-65. PubMed ID: 24398626
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of GOLPH3 promotes proliferation and tumorigenicity in breast cancer via suppression of the FOXO1 transcription factor.
Zeng Z; Lin H; Zhao X; Liu G; Wang X; Xu R; Chen K; Li J; Song L
Clin Cancer Res; 2012 Aug; 18(15):4059-69. PubMed ID: 22675169
[TBL] [Abstract][Full Text] [Related]
16. Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancer.
Noetzel E; Veeck J; Niederacher D; Galm O; Horn F; Hartmann A; Knüchel R; Dahl E
BMC Cancer; 2008 May; 8():154. PubMed ID: 18513385
[TBL] [Abstract][Full Text] [Related]
17. FOXO1 downregulation contributes to the oncogenic program of primary mediastinal B-cell lymphoma.
Xie L; Ritz O; Leithäuser F; Guan H; Färbinger J; Weitzer CD; Gehringer F; Bruederlein S; Holzmann K; Vogel MJ; Möller P; Wirth T; Ushmorov A
Oncotarget; 2014 Jul; 5(14):5392-402. PubMed ID: 24977668
[TBL] [Abstract][Full Text] [Related]
18. Clinical Significance of Expression Changes and Promoter Methylation of PLA2R1 in Tissues of Breast Cancer Patients.
Mitwally N; Yousef E; Abd Al Aziz A; Taha M
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751713
[TBL] [Abstract][Full Text] [Related]
19. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of DNAJC10 (ERDJ5) is associated with poor survival in breast cancer.
Acun T; Senses KM
Breast Cancer; 2020 May; 27(3):483-489. PubMed ID: 31902119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
